1.20. Analysis.
Comparison 1: Intramuscular (IM) hydroxyprogesterone caproate versus no treatment or placebo, Outcome 20: Retinopathy of prematurity
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.